Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Avistone Biotechnology Co., Ltd.

News headline image
Avistone Announces Results from a Sponsored Clinical Research Program Studying the Combination of Two Small-Molecule c-MET and EGFR Inhibitors in NSCLC Patients at the 2024 World Conference on Lung Cancer (WCLC)
From Avistone Biotechnology Co., Ltd.
Via Business Wire
News headline image
Avistone Announces Results from Two Sponsored Clinical Research Programs at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
From Avistone Biotechnology Co., Ltd.
Via Business Wire
News headline image
Avistone Announces the Approval of Vebreltinib as the First MET-TKI Treatment for a Rare Brain Glioma Subtype in China
From Avistone Biotechnology Co., Ltd.
Via Business Wire
News headline image
Avistone Biotechnology Announces Closing of Series B Financing
From Avistone Biotechnology Co., Ltd.
Via Business Wire
News headline image
Avistone Announces Phase II Results for Vebreltinib, a c-Met Tyrosine Kinase Inhibitor (TKI) at the European Society for Clinical Oncology (ESMO) Congress
From Avistone Biotechnology Co., Ltd.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.